<ѻýҕl>Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivorsѻýҕl> Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
<ѻýҕl>Chemotherapy Nausea Linked to Stress, Neuropsych Symptomsѻýҕl> High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
<ѻýҕl>Auricular Acupressure May Relieve Neuropathy in Breast Cancerѻýҕl> First randomized trial of the noninvasive technique in such patients Apr 22, 2021
<ѻýҕl>Are Post-Mastectomy Lymphedema Precautions Needed for All?ѻýҕl> Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
<ѻýҕl>Triple-Negative Breast Cancers Not All the Sameѻýҕl> Histology tied to treatment response, outcomes Apr 12, 2021
<ѻýҕl>Safety Reassurance for Major Class of Diabetes Drugsѻýҕl> Pooled trial data show no link to breast cancer Mar 24, 2021
<ѻýҕl>Time to Revisit Distant Nodal Status in Breast Cancer Curability?ѻýҕl> Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
<ѻýҕl>PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancerѻýҕl> No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
<ѻýҕl>New Targeted Therapies Show Promise in Cancerѻýҕl> Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
<ѻýҕl>Mammo Study: One Saves Lives, More Exams Save More Livesѻýҕl> Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
<ѻýҕl>FDA Panel Slows the Roll for Pembrolizumab in Breast Cancerѻýҕl> Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
<ѻýҕl>Has Pembrolizumab Finally Met an Indication FDA Doesn't Like?ѻýҕl> Agency staff skeptical of data in early breast cancer Feb 08, 2021
<ѻýҕl>Optimizing Neoadjuvant Therapy for Breast Cancerѻýҕl> ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<ѻýҕl>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻýҕl> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻýҕl>Oncotype DX Misses on Breast Cancer Risk in Black Womenѻýҕl> Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
<ѻýҕl>Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genesѻýҕl> Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
<ѻýҕl>Most Women Satisfied With 'Going Flat' After Mastectomyѻýҕl> Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
<ѻýҕl>PARP Inhibitors Linked With Blood Cancer Riskѻýҕl> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻýҕl>Add-On HDAC Inhibitor No Help in Breast Cancerѻýҕl> PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
<ѻýҕl>Broader Role for PARP Inhibitors in Breast Cancer?ѻýҕl> Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
<ѻýҕl>Online Tool Refines Individual Risks in Breast Cancerѻýҕl> RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020
<ѻýҕl>Doctor-Patient Discord in Reporting Radiation Toxicityѻýҕl> Physicians underrecognized substantial symptoms in more than half of patients Dec 11, 2020
<ѻýҕl>Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancerѻýҕl> No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
<ѻýҕl>Chemotherapy Improved TNBC Survival in Older Womenѻýҕl> Benefits noted in both node-negative and -positive disease, as well as for those with a comorbidity score greater than 0 Dec 08, 2020
<ѻýҕl>Study Reassures on MS Patients' Breast, Colorectal Cancer Riskѻýҕl> But higher incidence of other cancers in Canadian data Nov 25, 2020
<ѻýҕl>New Clinical Strategy for HR-Positive Breast Cancer?ѻýҕl> Ki67 values before, after preop endocrine therapy associated with recurrence risk Nov 17, 2020
<ѻýҕl>COVID Deaths Drop in the Hospitalized; Miracle Mouthwash? New Organ Discoveredѻýҕl> A daily roundup of news on COVID-19 and the rest of medicine Oct 21, 2020
<ѻýҕl>No Benefit With Anti-PD-L1 Drug in Metastatic TNBCѻýҕl> Lack of progression-free, overall survival boost with atezolizumab contrast with prior trial Sep 22, 2020
<ѻýҕl>Adjuvant Anti-CDK Thwarts Early Breast Cancer Recurrenceѻýҕl> Risk of invasive recurrence declines 25% in patients with high-risk disease Sep 20, 2020
<ѻýҕl>Newly Approved Drug Boosts Survival in Metastatic TNBCѻýҕl> Antibody-drug conjugate as third-line option improved survival, response rates Sep 20, 2020
<ѻýҕl>Skip Chemo for Older Patients With HER2+ Breast Cancer?ѻýҕl> Less than one-month survival loss at 3 years with trastuzumab monotherapy Sep 18, 2020
<ѻýҕl>Double Mastectomy Linked to Sexual, Body Image Issues in Young Womenѻýҕl> Pre-op counseling or decision aids could help women make better informed decisions Sep 16, 2020
<ѻýҕl>DCIS Tied to Higher Chance of Breast Cancer Deathѻýҕl> Black women and those under 40 at particularly high risk Sep 16, 2020
<ѻýҕl>Which Women Choose Hormones for Surgical Menopause?ѻýҕl> Understanding patterns of use can help improve targeting for education and counseling, researchers say Aug 12, 2020
<ѻýҕl>Survival Effect of pCR Elusive in Breast Cancerѻýҕl> 80% lower risk of recurrence with surrogate endpoint, but link to survival unproven Jul 23, 2020
<ѻýҕl>Older Age Should Not Rule Out Chemo in Breast Cancer Patientsѻýҕl> Providers should consider patient priorities when discussing treatment Jul 17, 2020
<ѻýҕl>The Serious Conversation: Delivering Bad News by Telemedicineѻýҕl> As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<ѻýҕl>Brief Quasi-Fasting Diet Boosts Breast Cancer Chemo Responseѻýҕl> Randomized trial in neoadjuvant setting Jun 28, 2020
<ѻýҕl>Pembrolizumab May Help in Triple-Negative Breast Cancerѻýҕl> Upfront therapy extends progression-free survival in metastatic disease, study shows Jun 01, 2020
<ѻýҕl>Surgery for Metastatic Breast Cancer Fails to Boost Overall Survivalѻýҕl> Cumulative data, though, don't rule out benefit for selected patients with de novo stage IV disease Jun 01, 2020